Amgen Inc. (TSX:AMGN)
Canada flag Canada · Delayed Price · Currency is CAD
25.61
-0.19 (-0.74%)
At close: Feb 3, 2026

Amgen Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
7,7114,0906,7176,5525,893
Depreciation & Amortization
5,1675,5924,0713,4173,398
Loss (Gain) From Sale of Assets
---567-
Asset Writedown & Restructuring Costs
----1,505
Loss (Gain) From Sale of Investments
-149-1,5541,01833
Stock-Based Compensation
-530431401341
Other Operating Activities
-2,920-1,236-710-1,501-715
Change in Accounts Receivable
-441-1,015-746-429
Change in Inventory
-2,532491-742-165
Change in Accounts Payable
-312-402154-69
Change in Income Taxes
--1,503-660-418-650
Change in Other Net Operating Assets
-5831,1021,019119
Operating Cash Flow
9,95811,4908,4719,7219,261
Operating Cash Flow Growth
-13.33%35.64%-12.86%4.97%-11.77%
Capital Expenditures
-1,858-1,096-1,112-936-880
Cash Acquisitions
---26,989-3,839-2,529
Investment in Securities
--1,672-1,3694,334
Other Investing Activities
-8550225100-192
Investing Cash Flow
-1,943-1,046-26,204-6,044733
Long-Term Debt Issued
--27,7776,9194,945
Long-Term Debt Repaid
--4,259-2,101-297-4,150
Net Debt Issued (Repaid)
--4,25925,6766,622795
Repurchase of Common Stock
--200--6,360-4,975
Common Dividends Paid
-5,100-4,832-4,556-4,196-4,013
Other Financing Activities
-5,759-124-72-103-78
Financing Cash Flow
-10,859-9,41521,048-4,037-8,271
Net Cash Flow
-2,8441,0293,315-3601,723
Free Cash Flow
8,10010,3947,3598,7858,381
Free Cash Flow Growth
-22.07%41.24%-16.23%4.82%-15.25%
Free Cash Flow Margin
22.04%31.10%26.11%33.37%32.26%
Free Cash Flow Per Share
14.9519.2113.6816.2414.63
Cash Interest Paid
-3,3002,4001,2001,200
Cash Income Tax Paid
-2,9003,4002,4001,900
Levered Free Cash Flow
7,60013,7263,3048,6907,515
Unlevered Free Cash Flow
9,32216,0175,8519,6488,270
Change in Working Capital
-2,365-484-733-1,194
Source: S&P Global Market Intelligence. Standard template. Financial Sources.